Anthem Biosciences shares listed on the market at a handsome premium on Monday, with its ₹3,395-crore IPO receiving unprecedented investor interest of nearly 64 times.
Anthem Biosciences made a stellar debut on the stock market on Monday, listing at a high of nearly 27 per cent over its IPO price. The public offer of ₹3,395 crore was priced at ₹540–₹570 per share. During the offer period (14–16 July), investors lapped it up and it closed with nearly 64 times more bids.
Anthem Biosciences’ stock opened at ₹723.05 per share on the National Stock Exchange (NSE), up 26.85 per cent from the issue price.
Its listing price on the Bombay Stock Exchange (BSE) was ₹723.10, an increase of 26.86 per cent. The company’s total market capital after listing reached ₹40,610.02 crore.
The company had raised ₹1,016 crore from anchor investors before the IPO. However, the listing on July 21 turned out to be slightly weaker than grey market estimates, which were expecting a gain of up to 31 per cent.
About of Company
Anthem Biosciences stands among India’s most respected names in the field of contract research and manufacturing (CRAMS), partnering with some of the world’s top pharmaceutical and biotech companies. We support our clients in developing and delivering innovative medicines, chemicals, and biotechnology-based products — faster, smarter, and more efficiently.
Established with the ambition to emerge as a global leader in life sciences, Anthem has earned recognition for delivering dependable, high-quality, and affordable research and manufacturing solutions. Our capabilities span the full spectrum — from early-stage discovery and pre-clinical development to process optimization and large-scale production of intermediates, active pharmaceutical ingredients (APIs), biopharmaceuticals, and specialty chemicals.
Our state-of-the-art facilities are designed to meet stringent international standards, equipped with advanced technology, and operated by a dedicated team of scientists, engineers, and professionals who bring creativity, expertise, and commitment to every challenge.
At Anthem, we are driven by a clear purpose: to create real value for our clients while maintaining the highest principles of ethics, safety, and environmental stewardship. Over time, we have become a trusted partner to global life sciences companies, playing a key role in bringing transformative healthcare solutions to people worldwide.
Disclaimer: The investment tips and opinions given here are the personal opinions of experts. These are not the opinions of Riskydollar or its team. Riskydollar advises all readers to consult a certified financial advisor before making any investment.